Morepen Laboratories Share Price
Small Cap | Pharmaceuticals and health care | NSE: MOREPENLAB | BSE: 500288
₹55.95 -2.60 (-4.44 %)
Last Updated: 11 Feb 2025 04:01 PM
Overview
Open (₹) 58.51
High (₹) 58.96
Low (₹) 55.43
Prev. Close (₹) 58.55
Volume 5,07,855
VWAP (₹) 61.67
ROCE (%) 15.61
Industry P/E 47.86
TTM P/E 24.33
P/B Ratio 3.37
Market Cap (₹) Cr.3,061.42
Dividend Yield (%)--
EPS (₹) 1.88
ROE11.34%
Sales Growth (%) 19.25
Profit Growth (%)149.82
Day Range
58.9658.96
52 Week Range
38.56100.80
Historical Returns
Returns (6M)
-8.05 %
Returns (1Y)
14.37 %
Returns (3Y)
32.74 %
Returns (5Y)
291.53 %
Returns (6M)
-8.05 %
Returns (1Y)
14.37 %
Returns (3Y)
32.74 %
Returns (5Y)
291.53 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (144.16%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 144.16% positive TTM EPS growth
- Positive ROC (9) indicates upward momentum.
Technicals![info_icon](/img/icons/info_icon.svg)
Technical Rating
RSI 60.73
MFI 35.10
ATR 3.16
Commodity Channel Index -98.08
ROC125 6.06
ROC21 -17.58
Williams %R -62.76
Resistance & Support![info_icon](/img/icons/info_icon.svg)
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 62.18 | 63.11 | 63.70 | 61.59 | 60.66 | 60.07 | 59.14 |
Week Ago | 66.27 | 67.52 | 69.55 | 64.24 | 62.99 | 60.96 | 59.71 |
Month Ago | 76.27 | 77.04 | 78.33 | 74.98 | 74.21 | 72.92 | 72.15 |
EMA & SMA![info_icon](/img/icons/info_icon.svg)
55.95
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 62.89
9 Day 63.42
10 Day 62.62
12 Day 63.67
14 Day 63.82
20 Day 65.15
26 Day 67.93
50 Day 74.76
100 Day 78.79
200 Day 68.70
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
MBL & COMPANY LIMITED | bulk | Sell | 07 Apr, 2022 | ₹46.88 | 19,94,735 | BSE |
MBL & COMPANY LIMITED | bulk | Buy | 07 Apr, 2022 | ₹46.73 | 24,05,735 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
22 Sept, 2022 | Liquid Holdings Private Limited | Acquisition | ₹25.00 | 50,00,000 | BSE |
22 Sept, 2022 | React Investments and Financial Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
22 Sept, 2022 | Mid-Med Financial Services and Investments Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Epitome Holdings Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Concept Credits and Consultants Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Brook Investments and Financial Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Square Investments and Financial Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Solitary Investments and Financial Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Solace Investments and Financial Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
05 Apr, 2022 | Seed Securities and Services Private Limited | Acquisition | ₹25.00 | 35,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
07 Feb, 2025 | NSE India | Morepen Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for Q3 FY 25 Results. |
06 Feb, 2025 | NSE India | Morepen Laboratories Limited has informed the Exchange about Link of Audio Recording |
06 Feb, 2025 | BSE India | Please find enclosed audio recording link of Analyst/ Investors Conference Call held today.\r\n |
06 Feb, 2025 | NSE India | Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024 |
06 Feb, 2025 | BSE India | Integrated Filing (Financial) for the Quarter and Nine Months ended December 31, 2024 |
06 Feb, 2025 | BSE India | Please find enclosed Monitoring Agency Report for the quarter ended December 31 2024 in respect of Company''s QIP Issue |
06 Feb, 2025 | NSE India | Please find enclosed monitoring agency report issued by Care Ratings Limited w.r.t., QIP Issue of the Company. |
06 Feb, 2025 | BSE India | Please find attached statement of Deviation & Variation for the quarter ended December 31, 2024 |
06 Feb, 2025 | NSE India | Morepen Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
06 Feb, 2025 | NSE India | Morepen Laboratories Limited has informed the Exchange about Investor Presentation |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 04 Feb, 2025 | 06 Feb, 2025 |
Quarterly Results | -- | 07 Nov, 2024 | 11 Nov, 2024 |
Quarterly Results | -- | 14 Aug, 2024 | 12 Aug, 2024 |
Audited Results | -- | 15 May, 2024 | 21 May, 2024 |
Quarterly Results | -- | 25 Jan, 2024 | 31 Jan, 2024 |
Quarterly Results | -- | 27 Oct, 2023 | 02 Nov, 2023 |
Quarterly Results | -- | 02 Aug, 2023 | 05 Aug, 2023 |
Audited Results | -- | 10 May, 2023 | 16 May, 2023 |
Quarterly Results | -- | 07 Feb, 2023 | 13 Feb, 2023 |
Quarterly Results | -- | 04 Nov, 2022 | 10 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Aug, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Morepen Laboratories
Morepen Laboratories is a Public Limited Listed company incorporated on 01/12/1984 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24231HP1984PLC006028 and registration number is 006028. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1537.59 Cr. and Equity Capital is Rs. 102.23 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Morepen Group
Founded
1984
Managing Director
Mr. Sushil Suri
NSE Symbol
MOREPENLAB
Morepen Laboratories Management
Name | Designation |
---|---|
Mr. Sushil Suri | Chairman & Managing Director |
Mr. Sanjay Suri | Whole Time Director |
Mr. Sukhcharan Singh | Independent Director |
Mr. Praveen Kumar Dutt | Independent Director |
Mr. Bhupender Raj Wadhwa | Independent Director |
Mrs. Savita | Independent Director |
Mr. Manoj Joshi | Independent Director |
Mr. Ranjit Khattar | Independent Director |
Mr. Sharad Jain | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,699.75 ₹1,732.10(-1.87%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,946.75 ₹5,938.80(0.13%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,453.15 ₹1,458.85(-0.39%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,450.30 ₹2,502.05(-2.07%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,209.80 ₹1,220.95(-0.91%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Morepen Laboratories
What is the share price of Morepen Laboratories?
The share price of Morepen Laboratories on 11 Feb, 2025 is ₹ 55.95.
What is 52W high and 52W low share price of Morepen Laboratories?
The highest and lowest 52W share prices of Morepen Laboratories are ₹ 100.800 and ₹ 38.560
What is the market cap of Morepen Laboratories?
The market capitalization of Morepen Laboratories as of 11 Feb, 2025 is ₹ 3,061.42 Crores
What is the P/E ratio of Morepen Laboratories?
The current P/E ratio of Morepen Laboratories as of 11 Feb, 2025 is 47.86
What is the PB ratio of Morepen Laboratories?
The PB ratio of Morepen Laboratories as of 11 Feb, 2025 is 3.37
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)